Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Cardiologist to pay $6.5M for complex fraud scheme | Martha Gulati on cardiac CT | EP studies during TAVR
Thursday, September 21, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Cardiologist to pay $6.5M after trading kickbacks for imaging referrals in complex fraud scheme

In addition to the hefty fine, the New York physician has agreed to relinquish ownership of his cardiology practice after exchanging kickbacks for PET and SPECT referrals for more than a decade.

READ MORE >
doctor in handcuffs after being arrested
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist to pay $6.5M after trading kickbacks for imaging referrals in complex fraud scheme

Share on Twitter Share on Facebook Share on Linkedin
doctor in handcuffs after being arrested
In addition to the hefty fine, the New York physician has agreed to relinquish ownership of his cardiology practice after exchanging kickbacks for PET and SPECT referrals for more than a decade.
READ MORE >

Cardiac CT gaining popularity due to chest pain guidelines, cost savings

Cardiologist Martha Gulati, MD, lead author of the 2021 chest pain guidelines, explained how the document may have contributed to the rise of cardiac CT. "These guidelines have made it harder for people to push back and say you don't need this test," she said. 

READ MORE >
Video interview with Martha Gulati, MD, was the lead author of the 2021 chest pain guidelines and shares impacts.
Share on Twitter Share on Facebook Share on Linkedin

Cardiac CT gaining popularity due to chest pain guidelines, cost savings

Share on Twitter Share on Facebook Share on Linkedin
Video interview with Martha Gulati, MD, was the lead author of the 2021 chest pain guidelines and shares impacts.
Cardiologist Martha Gulati, MD, lead author of the 2021 chest pain guidelines, explained how the document may have contributed to the rise of cardiac CT. "These guidelines have made it harder for people to push back and say you don't need this test," she said. 
READ MORE >

EP studies during TAVR are safe and effective, new pilot study confirms

New research in JACC: Cardiovascular Interventions explored the potential of performing EP studies before and after valve deployment. TAVR operators handled all catheter manipulations, and EP specialists were on hand to capture the necessary measurements. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

EP studies during TAVR are safe and effective, new pilot study confirms

Share on Twitter Share on Facebook Share on Linkedin
New research in JACC: Cardiovascular Interventions explored the potential of performing EP studies before and after valve deployment. TAVR operators handled all catheter manipulations, and EP specialists were on hand to capture the necessary measurements. 
READ MORE >

Featured Articles

The 50 best heart hospitals in the world

The new ranking includes a total of 300 hospitals from around the globe. Did your facility make the cut? 

READ MORE >
Newsweek ranked the 50 best heart hospitals in the world
Share on Twitter Share on Facebook Share on Linkedin

The 50 best heart hospitals in the world

Share on Twitter Share on Facebook Share on Linkedin
Newsweek ranked the 50 best heart hospitals in the world
The new ranking includes a total of 300 hospitals from around the globe. Did your facility make the cut? 
READ MORE >

Previewing ASNC 2023: Why nuclear cardiology needs to evolve

ASNC President President Mouaz Al-Mallah, MD, said nuclear cardiology needs to upgrade old imaging systems and embrace new technology to deliver better value for patients. 

READ MORE >
Video interview with ASNC President President Mouaz Al-Mallah, MD, who explains why nuclear cardiology needs to upgrade its technology to be competitive. #ASNC #ASNC2023 #ASNC23
Share on Twitter Share on Facebook Share on Linkedin

Previewing ASNC 2023: Why nuclear cardiology needs to evolve

Share on Twitter Share on Facebook Share on Linkedin
Video interview with ASNC President President Mouaz Al-Mallah, MD, who explains why nuclear cardiology needs to upgrade its technology to be competitive. #ASNC #ASNC2023 #ASNC23
ASNC President President Mouaz Al-Mallah, MD, said nuclear cardiology needs to upgrade old imaging systems and embrace new technology to deliver better value for patients. 
READ MORE >

Cooling device now approved by FDA to reduce risk of ablation-related esophageal injuries

Already approved for temperature management, the single-use ensoETM device is now cleared for another use: minimizing the risk of potentially fatal injuries to the patient's esophagus during radiofrequency ablation procedures. 

READ MORE >
Attune Medical has been granted De Novo marketing authorization from the US Food and Drug Administration (FDA) for its ensoETM device to reduce the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac ablation procedures.
Share on Twitter Share on Facebook Share on Linkedin

Cooling device now approved by FDA to reduce risk of ablation-related esophageal injuries

Share on Twitter Share on Facebook Share on Linkedin
Attune Medical has been granted De Novo marketing authorization from the US Food and Drug Administration (FDA) for its ensoETM device to reduce the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac ablation procedures.
Already approved for temperature management, the single-use ensoETM device is now cleared for another use: minimizing the risk of potentially fatal injuries to the patient's esophagus during radiofrequency ablation procedures. 
READ MORE >

In Case You Missed It

How to create a cardio-oncology program

Juan Carlos Plana Gomez, MD, discussed how cardiology and oncology programs can work together to provide high-quality patient care.

READ MORE >
Video of Juan Carlos Plana Gomez MD explaining how to create a cardio-oncology program at ASE 2023. #ASE #ASE23 #ASE2023
Share on Twitter Share on Facebook Share on Linkedin

How to create a cardio-oncology program

Share on Twitter Share on Facebook Share on Linkedin
Video of Juan Carlos Plana Gomez MD explaining how to create a cardio-oncology program at ASE 2023. #ASE #ASE23 #ASE2023
Juan Carlos Plana Gomez, MD, discussed how cardiology and oncology programs can work together to provide high-quality patient care.
READ MORE >

Boston Scientific gains FDA approval for Watchman FLX Pro LAAC device

This represents the latest iteration of the Watchman technology, which was first approved by the FDA back in 2020. 

READ MORE >
Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for its Watchman FLX Pro left atrial appendage closure (LAAC) device
Share on Twitter Share on Facebook Share on Linkedin

Boston Scientific gains FDA approval for Watchman FLX Pro LAAC device

Share on Twitter Share on Facebook Share on Linkedin
Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for its Watchman FLX Pro left atrial appendage closure (LAAC) device
This represents the latest iteration of the Watchman technology, which was first approved by the FDA back in 2020. 
READ MORE >

In Other News

DOJ accuses addiction recovery providers of offering kickbacks to patients, running 'unsafe' facilities

Brookline-based Bournewood Health Systems and First Psychiatric Planners are also accused of pushing patients to attend facilities known to be overcrowded and dangerous. 

READ MORE >
unhappy desperate girl on psychiatric couch patient fraud
Share on Twitter Share on Facebook Share on Linkedin

DOJ accuses addiction recovery providers of offering kickbacks to patients, running 'unsafe' facilities

Share on Twitter Share on Facebook Share on Linkedin
unhappy desperate girl on psychiatric couch patient fraud
Brookline-based Bournewood Health Systems and First Psychiatric Planners are also accused of pushing patients to attend facilities known to be overcrowded and dangerous. 
READ MORE >

Federal regulation of AI: What the likely framers and innovators are saying now

Last week brought the latest in an occasional series of conversations on AI between governmental leaders and Big Tech honchos.

READ MORE >
artificial intelligence regulation legislation
Share on Twitter Share on Facebook Share on Linkedin

Federal regulation of AI: What the likely framers and innovators are saying now

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence regulation legislation
Last week brought the latest in an occasional series of conversations on AI between governmental leaders and Big Tech honchos.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: TAVR vs. SAVR | FDA clears AI tech | Payment model confusion | Private equity & cardiology | Injuries after PCI
Heart surgery kits recalled | Sex-specific outcomes after TAVR & SAVR | A new risk calculator | FDA clears tricuspid valve
Thousands of heart surgery kits recalled | TAVR for AR linked to 'encouraging' data | Carotid IVL | Progress for new HCM drug
AI company founded by cardiologist makes big splash | Getting clinicians on the same page | Kidney injuries after PCI
Sweeping TAVR changes on the way | Pushing back against AI-powered prior authorization | FDA highlights recall after injuries
Cardiologists added to payment model by mistake | Sex-specific outcomes after TAVR & SAVR | FDA clears new AI software
Private equity unlikely to dominate cardiology | Cardiology opposes Medicare AI prior authorization | New AATS leaders

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup